Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives. | Molecules | 2018 | 30373212 | PubTator, text mining | PubMed |
| Secretome proteins regulate comparative osteogenic and adipogenic potential in bone marrow and dental stem cells. | Biochimie | 2018 | 30367923 | PubTator, text mining | PubMed |
| NTRK fusion-positive cancers and TRK inhibitor therapy. | Nat Rev Clin Oncol | 2018 | 30333516 | PubTator, text mining | PubMed |
| The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. | Sci Rep | 2018 | 30333500 | PubTator, text mining | PubMed |
| Ethanol-Induced Behavioral Sensitization Alters the Synaptic Transcriptome and Exon Utilization in DBA/2J Mice. | Front Genet | 2018 | 30319688 | PubTator, text mining | PubMed |
| Aptamer-based proteomics of serum and plasma in acquired aplastic anemia. | Exp Hematol | 2018 | 30312735 | PubTator, text mining | PubMed |
| Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma. | BMC Cancer | 2018 | 30305059 | PubTator, text mining | PubMed |
| Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence. | Sci Rep | 2018 | 30297788 | PubTator, text mining | PubMed |
| Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline. | Nat Commun | 2018 | 30275468 | PubTator, text mining | PubMed |
| Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer. | Anticancer Res | 2018 | 30275180 | PubTator, text mining | PubMed |
| Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era. | Lung Cancer | 2018 | 30268445 | PubTator, text mining | PubMed |
| miR-199b-5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1. | Oncol Lett | 2018 | 30250555 | PubTator, text mining | PubMed |
| Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1. | Oncogenesis | 2018 | 30250018 | PubTator, text mining | PubMed |
| Does Axl have potential as a therapeutic target in pancreatic cancer? | Expert Opin Ther Targets | 2018 | 30244621 | PubTator, text mining | PubMed |
| Aptamer-based search for correlates of plasma and serum water T2: implications for early metabolic dysregulation and metabolic syndrome. | Biomark Res | 2018 | 30237882 | PubTator, text mining | PubMed |
| Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR). | J Thorac Dis | 2018 | 30233859 | PubTator, text mining | PubMed |
| Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. | ESMO Open | 2018 | 30233821 | PubTator, text mining | PubMed |
| Liquid Biopsy to Identify Actionable Genomic Alterations. | Am Soc Clin Oncol Educ Book | 2018 | 30231331 | PubTator, text mining | PubMed |
| Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering. | J Biol Eng | 2018 | 30220913 | PubTator, text mining | PubMed |
| A curated target gene pool assisting disease prediction and patient-specific biomarker selection for lung squamous cell carcinoma. | Oncol Lett | 2018 | 30197682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=81